1 Otto-Lambertz C, Yagdiran A, Wallscheid F, Eysel P, Jung N. Dtsch Arztebl Int. 2017 May 26;114(20):347-353. doi: 10.3238/arztebl.2017.0347. Periprosthetic Infection in Joint Replacement.
2 Gundtoft PH, Overgaard S, Schonheyder HC, Moller JK, Kjaersgaard-Andersen P, Pedersen AB. The "true" incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties. Acta Orthop 2015. January 30:1–9.
3 Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011;93:2242–2248. doi: 10.2106/JBJS.J.01413.
4 Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, et al. The 2018 Definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplast 2018. doi:10.1016/j.arth.2018.02.078..
5 Bjerke-Kroll B.T., Christ A.B., McLawhorn A.S., Sculco P.K., Jules-Elysée K.M., Sculco T.P. Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J. Arthroplasty. 2014;29(5):877–882. doi: 10.1016/j.arth.2013.09.053.
6 Yuan K, Chen HL, Cui ZM. Diagnostic accuracy of C-reactive protein for periprosthetic joint infection: a meta-analysis. Surg Infect (Larchmt) 2014;15:548–559. doi: 10.1089/sur.2013.066.
7 Kheir MM, Tan TL, Shohat N, Foltz C, Parvizi J. Routine Diagnostic Tests for Periprosthetic Joint Infection Demonstrate a High False-Negative Rate and Are Influenced by the Infecting Organism. J Bone Joint Surg Am. 2018 Dec 5;100(23):2057-2065. doi: 10.2106/JBJS.17.01429.
8 Glehr M, Friesenbichler J, Hofmann G, Bernhardt GA, Zacherl M, Avian A, Windhager R, Leithner A. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res. 2013 Aug;471(8):2621-8. doi: 10.1007/s11999-013-2998-3. Epub 2013 Apr 23
9 Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res. 2014 Nov;472(11):3254-62. doi: 10.1007/s11999-014-3543-8
10 Patel R, Alijanipour P, Parvizi J., Advancements in Diagnosing Periprosthetic Joint Infections after Total Hip and Knee Arthroplasty., Open Orthop J. 2016 Nov 30;10:654-661. doi: 10.2174/1874325001610010654. eCollection 2016.
11 Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217.
12 Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38(Pt 5):483–493.
13 Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo JA, Leone C, Okay TS. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child. 2006;91(2):117–120.
14 Pontrelli G, De Crescenzo F, Buzzetti R, Jenkner A, Balduzzi S, Calò Carducci F, Amodio D, De Luca M, Chiurchiù S, Davies EH, Copponi G, Simonetti A, Ferretti E, Di Franco V, Rasi V, Della Corte M, Gramatica L, Ciabattini M, Livadiotti S, Rossi P. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis. 2017 Apr 24;17(1):302. doi: 10.1186/s12879-017-2396-7.
15 Sa-Ngasoongsong P, Wongsak S, Jarungvittayakon C, Limsamutpetch K, Channoom T, Kawinwonggowit V. Comparison of Synovial Fluid and Serum Procalcitonin for Diagnosis of Periprosthetic Joint Infection: A Pilot Study in 32 Patients. Biomed Res Int. 2018 Oct 1;2018:8351308. doi: 10.1155/2018/8351308. eCollection 2018.
16 Morgenthaler N. G., Struck J., Fischer-Schulz C., Seidel-Mueller E., Beier W., Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clinical Laboratory. 2002;48(5-6):263–270.
17 Ferriere F. Procalcitonin, a new marker for bacterial infections. Annales de Biologie Clinique. 2000;58(1):49–59.
18 Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79(6):1605–1608.
19 Wegner, A., S. Elsenbruch, J. Maluck, J.S. Grigoleit, H. Engler, M. Jager, I. Spreitzer, M. Schedlowski Benson S. Inflammation-induced hyperalgesia: effects of timing, dosage, and negative affect on somatic pain sensitivity in human experimental endotoxemia. Brain Behav Immun, 2014. 41: p. 46-54.
20 Cats-Baril W, Gehrke T, Huff K, Kendoff D, Maltenfort M, Parvizi J. International consensus on periprosthetic joint infection: description of the consensus process. Clin Orthop Relat Res. 2013;471:4065–4075. doi: 10.1007/s11999-013-3329-4.
21 Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, et al. The 2018 Definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplast 2018. doi:10.1016/j.arth.2018.02.078.
22 Romanò CL, et al. The W.A.I.O.T. Definition of High-Grade and Low-Grade Peri-Prosthetic Joint Infection. J Clin Med 2019. PMID 31083439 Free PMC article.
23 Bilgen O, Atici T, Durak K. Karaeminoğullari, Bilgen MS. C-reactive protein values and erythrocyte sedimentation rates after total hip and total knee arthroplasty. J Int Med Res. 2001;29:7–12. doi: 10.1177/147323000102900102.
24 Larsson S, Thelander U, Friberg S. C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop Relat Res. 1992;275:237–242.
25 Ellenrieder M, Lenz R, Haenle M, Bader R, Mittelmeier W. Two-stage revision of implant-associated infections after total hip and knee arthroplasty. GMS Krankenhhyg Interdiszip. 2011;6(1):Doc17. doi: 10.3205/dgkh000174. Epub 2011 Dec 15.
26 Lee Y. S., Koo K., Kim H. J., et al. Synovial Fluid Biomarkers for the Diagnosis of Periprosthetic Joint Infection. The Journal of Bone & Joint Surgery. 2017;99(24):2077–2084. doi: 10.2106/JBJS.17.00123.
27 Vicenti G, Bizzoca D, Nappi V, Pesce V, Solarino G, Carrozzo M, Moretti F, Dicuonzo F, Moretti B. Serum biomarkers in the diagnosis of periprosthetic joint infection: consolidated evidence and recent developments. Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):43-50. doi: 10.26355/eurrev_201904_17473.
28 Xie K., Dai K., Qu X., Yan M. Serum and Synovial Fluid Interleukin-6 for the Diagnosis of Periprosthetic Joint Infection. Scientific Reports. 2017;7(1) doi: 10.1038/s41598-017-01713-4.
29 Yuan K, Li WD, Qiang Y, Cui ZM. Comparison of procalcitonin and C-reactive protein for the diagnosis of periprosthetic joint infection before revision total hip arthroplasty. Surg Infect (Larchmt). 2015 Apr;16(2):146-50. doi: 10.1089/sur.2014.034. Epub 2015 Feb 6.
30 Yoon JR, Yang SH, Shin YS. Diagnostic accuracy of interleukin-6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta-analysis. Int Orthop. 2018 Jun;42(6):1213-1226. doi: 10.1007/s00264-017-3744-3. Epub 2018 Jan 2.
31 Parvizi J, Jacovides C, Adeli B, Jung KA, Hozack WJ Mark B. Coventry Award: synovial C-reactive protein: a prospective evaluation of a molecular marker for periprosthetic knee joint infection. Clin Orthop Relat Res. 2012 Jan; 470(1):54-60.
32 Ghanem E, Antoci V Jr, Pulido L, Joshi A, Hozack W, Parvizi J The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis. 2009 Nov; 13(6):e444-9.
33 Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, Duncan CP. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty: a prospective evaluation. J Bone Joint Surg Am. 2007;89:1409–1416. doi: 10.2106/JBJS.D.02602.
34 Omar M, Ettinger M, Reichling M, Petri M, Guenther D, Gehrke T, Krettek C, Mommsen P. Synovial C-reactive protein as a marker for chronic periprosthetic infection in total hip arthroplasty. Bone Joint J. 2015 Feb;97-B(2):173-6. doi: 10.1302/0301-620X.97B2.34550.
35 Tetreault MW, Wetters NG, Moric M, Gross CE, Della Valle CJ. Is synovial C-reactive protein a useful marker for periprosthetic joint infection? Clin Orthop Relat Res. 2014 Dec;472(12):3997-4003. doi: 10.1007/s11999-014-3828-y. Epub 2014 Jul 29.
36 White SH, Wimley WC, Selsted ME Structure, function, and membrane integration of defensins. Curr Opin Struct Biol. 1995 Aug; 5(4):521-7.
37 Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C, Goldberg B The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res. 2014 Dec; 472(12):4006-9.
38 Shahi A, Parvizi J. The role of biomarkers in the diagnosis of periprosthetic joint infection. EFORT Open Rev. 2017 Mar 13;1(7):275-278. doi: 10.1302/2058-5241.1.160019. eCollection 2016 Jul.
39 Frangiamore SJ, Saleh A, Grosso MJ, Kovac MF, Higuera CA, Iannotti JP, Ricchetti ET. α-Defensin as a predictor of periprosthetic shoulder infection. J Shoulder Elbow Surg. 2015 Jul;24(7):1021-7. doi: 10.1016/j.jse.2014.12.021. Epub 2015 Feb 8.
40 Randau TM, Friedrich MJ, Wimmer MD, Reichert B, Kuberra D, Stoffel-Wagner B, Limmer A, Wirtz DC, Gravius S. Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening.PLoS One. 2014 Feb 21;9(2):e89045. doi: 10.1371/journal.pone.0089045. eCollection 2014.
41 Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C.Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br. 2007 Jan;89(1):94-9.
42 Klement MR, Siddiqi A, Rock JM, Chen AF, Bolognesi MP, Seyler TM. Positive Blood Cultures in Periprosthetic Joint Infection Decrease Rate of Treatment Success. J Arthroplasty. 2018 Jan;33(1):200-204.e1. doi: 10.1016/j.arth.2017.08.034. Epub 2017 Sep 4.
43 Lucas VS, Gafan G, Dewhurst S, Roberts GJ. Prevalence, intensity and nature of bacteraemia after toothbrushing. J Dent. 2008;36(7):481–487.
44 Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117(24):3118–3125
45 Schlein RA, Kudlick EM, Reindorf CA, Gregory J, Royal GC. Toothbrushing and transient bacteremia in patients undergoing orthodontic treatment. Am J Orthod Dentofacial Orthop. 1991;99(5):466–472.
46 Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018 Nov 14;13(11):e0206527. doi: 10.1371/journal.pone.0206527. eCollection 2018.
47 Herget-Rosenthal S, Klein T, Marggraf G, Hirsch T, Jakob HG, Philipp T, Kribben A. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol. 2005 Feb;61(2):180-6.
48 Kheir MM, Tan TL, Shohat N, Foltz C, Parvizi J. Routine Diagnostic Tests for Periprosthetic Joint Infection Demonstrate a High False-Negative Rate and Are Influenced by the Infecting Organism. J Bone Joint Surg Am. 2018 Dec 5;100(23):2057-2065. doi: 10.2106/JBJS.17.01429.
49 Scemama C., Anract P., Dumaine V., Babinet A., Courpied J.P., Hamadouche M. Does vitamin E-blended polyethylene reduce wear in primary total hip arthroplasty: a blinded randomised clinical trial. Int Orthop. 2017 Jun;41(6):1113-1118. doi: 10.1007/s00264-016-3320-2. Epub 2016 Nov 4.